BiotechTube
Home/C4 Therapeutics/Andrew J. Hirsch
AJ

Andrew J. Hirsch

Chief Executive Officer, President & Director

C4 Therapeutics

Therapeutic Areas

Oncology

C4 Therapeutics Pipeline

DrugIndicationPhase
Cemsidomide (CFT7455)Relapsed/Refractory Multiple MyelomaPhase 1/2
CFT8919EGFR L858R-mutated Non-Small Cell Lung Cancer (NSCLC)Phase 1

Leadership Team at C4 Therapeutics

SO
Stephanie Oestreich, MBA
Chief Financial Officer
AC
Adam Crystal, M.D., Ph.D.
Chief Medical Officer
JD
John D. Chodera, Ph.D.
Chief Scientific Officer
ML
Marc L. Cohen
Co-Founder & Chairman of the Board
View full C4 Therapeutics profile